{
  "metadata": {
    "claims_file": "data/claims/Flublok_Claims.json",
    "documents": [
      "FlublokPI"
    ],
    "total_claims": 9,
    "started_at": "2025-07-28T20:17:02.688252",
    "completed_at": "2025-07-28T20:17:49.494147"
  },
  "claims": {
    "claim_000": {
      "claim_id": "claim_000",
      "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
      "started_at": "2025-07-28T20:17:02.688289",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:09.043814"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:09.044129"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:09.044136"
    },
    "claim_001": {
      "claim_id": "claim_001",
      "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
      "started_at": "2025-07-28T20:17:09.044167",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:12.223798"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:12.224329"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:12.224335"
    },
    "claim_002": {
      "claim_id": "claim_002",
      "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
      "started_at": "2025-07-28T20:17:12.224366",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:16.357824"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:16.358580"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:16.358591"
    },
    "claim_003": {
      "claim_id": "claim_003",
      "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
      "started_at": "2025-07-28T20:17:16.358648",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:21.965672"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:21.966354"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:21.966363"
    },
    "claim_004": {
      "claim_id": "claim_004",
      "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
      "started_at": "2025-07-28T20:17:21.966415",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:27.971712"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:27.972483"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:27.972491"
    },
    "claim_005": {
      "claim_id": "claim_005",
      "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
      "started_at": "2025-07-28T20:17:27.972532",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:32.361764"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:32.366199"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:32.366221"
    },
    "claim_006": {
      "claim_id": "claim_006",
      "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
      "started_at": "2025-07-28T20:17:32.366506",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:38.713642"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:38.714957"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:38.714998"
    },
    "claim_007": {
      "claim_id": "claim_007",
      "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
      "started_at": "2025-07-28T20:17:38.715153",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:45.158008"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:45.158740"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:45.158748"
    },
    "claim_008": {
      "claim_id": "claim_008",
      "claim": "Flublok contains 45 micrograms (mcg) of HA per strain vs 15 mcg of HA per strain in a standard-dose influenza vaccine.",
      "started_at": "2025-07-28T20:17:45.158784",
      "documents": {
        "FlublokPI": {
          "document": "FlublokPI",
          "agents_run": [
            {
              "agent": "supporting_evidence",
              "success": true,
              "timestamp": "2025-07-28T20:17:49.493582"
            },
            {
              "agent": "regex_verifier",
              "success": true,
              "timestamp": "2025-07-28T20:17:49.494122"
            }
          ],
          "final_judgment": null,
          "success": true
        }
      },
      "completed_at": "2025-07-28T20:17:49.494134"
    }
  },
  "summary": {
    "total_claim_document_pairs": 9,
    "successfully_processed": 9,
    "processing_rate": 1.0,
    "judgment_distribution": {
      "strongly_supported": 0,
      "supported": 0,
      "weakly_supported": 0,
      "unsupported": 0
    }
  }
}